世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

フローサイトメトリ(フロー細胞分析)市場:技術毎(細胞、ビーズ)、製品毎(アナライザ、ソータ、試薬、消耗品、ソフトウェア)、エンドユーザ毎(学術、研究所、病院、臨床検査、医薬・バイオ技術)、用途毎 - 2025年までの世界市場予測

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents, Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2020年1月US$4,950
シングルユーザライセンス
249 244

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)のフローサイトメトリ(フロー細胞分析)市場に関する調査レポートです。

“The global flow cytometry market is projected to grow at a CAGR of 8.3%.”

The global flow cytometry market size is projected to reach USD 6.4 billion by 2025 from USD 4.0 billion in 2019, growing at a CAGR of 8.3% from 2019 to 2025. The key factors driving the growth of this market include technological advancements in flow cytometers, the increasing adoption of flow cytometry in research and clinical trials, growing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software, high incidence and prevalence of target diseases, and the availability of novel products.

“The bead-based technology segment is expected to grow at the fastest rate during the forecast period.”

By technology, the flow cytometry market is classified into cell-based and bead-based. In 2019, the cell-based flow cytometry segment accounted for the largest share of the market. However, the bead-based flow cytometry segment is expected to grow at the highest CAGR during the forecast period. The growth of the bead-based flow cytometry segment can be attributed to the procedural advantages offered by this technology over other cell-based technology, such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed.
 
“The reagents and consumables segment is expected to grow at the highest CAGR during 2019-2025.”

On the basis of product and service, the flow cytometry market is categorized into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables segment is expected to witness the highest growth during the forecast period due to the development and commercialization of high-quality application-specific reagents and assays and continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities).

“The Asia Pacific to witness the highest growth during the forecast period (2019-2025)”

North America is expected to hold the largest share of the global flow cytometry market in 2019 followed by Europe. However, the Asia Pacific is expected to grow at the fastest rate during the forecast period. The increasing participation of China, India, Japan, Australia, and South Korea in flow cytometry-based research; expansion of research infrastructure in the region; and public-private finding aimed towards boosting advance research practices are the key factors responsible for the growth of this market in the Asia Pacific.

Breakdown of supply-side primary interviews:

- By Company Type: Tier 1-33%, Tier 2-46%, and Tier 3-21%
- By Designation: C-level-26%, Director-level-20%, and Others-54%
- By Region: North America-33%, Europe-29%, APAC-24%, and RoW-14%

The major players in the market include Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioM-rieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US), Cytek Biosciences (US), and Apogee Flow Systems Ltd. (UK).

Research Coverage

This report studies the flow cytometry market based on technology, product and service, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the flow cytometry market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.



目次

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY USED FOR THE STUDY 27
1.5 STAKEHOLDERS 27

2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 29
2.1.2 PRIMARY DATA 29
2.1.2.1 Key data from primary sources 30
2.1.2.2 Breakdown of primaries 31
2.2 MARKET ESTIMATION METHODOLOGY 31
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 32
2.2.2 USAGE-BASED MARKET ESTIMATION 33
2.2.3 PRIMARY RESEARCH VALIDATION 34
2.3 DATA TRIANGULATION METHODOLOGY 35
2.4 RESEARCH ASSUMPTIONS 36
2.5 RESEARCH LIMITATIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 42
4.1 FLOW CYTOMETRY: MARKET OVERVIEW 42
4.2 FLOW CYTOMETRY PRODUCTS & SERVICES MARKET, 2019 VS. 2025 43
4.3 FLOW CYTOMETRY MARKET, BY APPLICATION, 2019 VS. 2025 44
4.4 FLOW CYTOMETRY MARKET, BY END USER, 2019 VS. 2025 44
4.5 GEOGRAPHICAL SNAPSHOT OF THE FLOW CYTOMETRY MARKET 45

5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
5.2.1 DRIVERS 47
5.2.1.1 Technological advancements 47
5.2.1.2 Increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software 49
5.2.1.3 Growing adoption of flow cytometry techniques in research and academia 50
5.2.1.4 Growing public-private initiatives in the field of immunology and immuno-oncology research 51
5.2.1.5 Rising global incidence and prevalence of HIV/AIDS and cancer 52
5.2.1.6 Increased availability of application-specific products 54
5.2.2 RESTRAINTS 54
5.2.2.1 Significant product costs 54
5.2.2.2 Limited purchasing power of end users in emerging countries 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Growing market presence in emerging countries 55
5.2.3.2 Evolving pipeline for stem cell research 56
5.2.3.3 Adoption of recombinant DNA technology for antibody production 57
5.2.3.4 Evolution of tandem flow cytometry technologies 57
5.2.4 CHALLENGES 58
5.2.4.1 Inadequate infrastructure for research in emerging countries 58
5.2.4.2 Complexities related to reagent development 58
5.2.4.3 Dearth of well-trained and skilled professionals 58
5.3 REGULATORY CHALLENGES 59
5.3.1 STRINGENT FDA REQUIREMENTS 59
5.3.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE 59
5.3.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 59
5.3.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 59
5.3.5 GREATER GLOBAL RECOGNITION FOR IVD–CE MARK APPROVALS 60
5.4 US REIMBURSEMENT SCENARIO 60

6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 61
6.1 INTRODUCTION 62
6.2 CELL-BASED FLOW CYTOMETRY 63
6.2.1 RESEARCH & DEVELOPMENT ON NOVEL THERAPEUTIC AGENTS WILL DRIVE THE GROWTH OF THE CELL-BASED FLOW CYTOMETRY MARKET 63
6.3 BEAD-BASED FLOW CYTOMETRY 64
6.3.1 PROCEDURAL ADVANTAGES OF BEAD-BASED FLOW CYTOMETRY HAVE DRIVEN MARKET GROWTH 64

7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 66
7.1 INTRODUCTION 67
7.2 REAGENTS & CONSUMABLES 68
7.2.1 REAGENTS AND CONSUMABLES WILL GENERATE THE HIGHEST REVENUE IN THE FLOW CYTOMETRY MARKET DURING THE FORECAST PERIOD 68
7.3 FLOW CYTOMETRY INSTRUMENTS 71
7.3.1 CELL ANALYZERS 75
7.3.1.1 High-range cell analyzers 78
7.3.1.1.1 High-range cell analyzers account for the largest share of the cell analyzers market 78
7.3.1.2 Mid-range cell analyzers 79
7.3.1.2.1 Wide availability of compact and high-performance analyzers in this price range support market growth 79
7.3.1.3 Low-range cell analyzers 80
7.3.1.3.1 Low-range analyzers find significant adoption among price-sensitive end users 80
7.3.2 CELL SORTERS 80
7.3.2.1 High-range cell sorters 84
7.3.2.1.1 High-range cell sorters dominate the market 84
7.3.2.2 Mid-range cell sorters 85
7.3.2.2.1 Product launches and the cost-efficiency of mid-range sorters have enabled the growth of this market segment 85
7.3.2.3 Low-range cell sorters 86
7.3.2.3.1 Increasing commercialization of affordable products has driven the adoption of low-range cell sorters 86
7.4 SERVICES 86
7.4.1 CUSTOM FLOW CYTOMETRY ASSAY DEVELOPMENT SERVICES HAVE HELPED IN THE ADVANCEMENT OF RESEARCH, ESPECIALLY IN CELL BIOLOGY 86
7.5 SOFTWARE 89
7.5.1 AVAILABILITY OF A WIDE RANGE OF ANALYSIS SOFTWARE AND ADVANCEMENTS ARE DRIVING MARKET GROWTH 89
7.6 ACCESSORIES 92

8 FLOW CYTOMETRY MARKET, BY APPLICATION 95
8.1 INTRODUCTION 96
8.2 RESEARCH APPLICATIONS 97
8.2.1 PHARMACEUTICALS & BIOTECHNOLOGY 98
8.2.1.1 Drug discovery 99
8.2.1.1.1 Wide usage of flow cytometry in drug discovery is
the primary driver of market growth 99
8.2.1.2 Stem cell research 100
8.2.1.2.1 Accuracy and precision of flow cytometry have made it a prominent tool in stem cell research 100

8.2.1.3 In vitro toxicity testing 101
8.2.1.3.1 Need to reduce time and cost of drug development processes will be a key factor driving market growth 101
8.2.2 IMMUNOLOGY 102
8.2.2.1 Flow cytometry plays a vital role in immunology studies 102
8.2.3 CELL SORTING 103
8.2.3.1 Increase in cell-based research activity has boosted growth in this application segment 103
8.2.4 APOPTOSIS 104
8.2.4.1 Flow cytometry techniques are used to identify changes occurring during apoptosis 104
8.2.5 CELL CYCLE ANALYSIS 105
8.2.5.1 Any abnormality in DNA content can be detected using flow cytometry 105
8.2.6 CELL VIABILITY 105
8.2.6.1 Cell viability is a key parameter studied using flow cytometry 105
8.2.7 CELL COUNTING 106
8.2.7.1 Flow cytometry allows for easy differentiation of cells via scattering
or staining 106
8.2.8 OTHER RESEARCH APPLICATIONS 107
8.3 CLINICAL APPLICATIONS 108
8.3.1 CANCER 109
8.3.1.1 Cancer applications include the determination of tumor malignancy and chromosome enumeration 109
8.3.2 HEMATOLOGY 110
8.3.2.1 Flow cytometry can help identify a wide variety of cell surfaces and cytoplasmic antigens 110
8.3.3 IMMUNODEFICIENCY DISEASES 111
8.3.3.1 Flow cytometry allows for simultaneous, multi-parametric cell analysis 111
8.3.4 ORGAN TRANSPLANTATION 112
8.3.4.1 Use of flow cytometry to reduce organ rejection rates has contributed to market growth 112
8.3.5 OTHER CLINICAL APPLICATIONS 113
8.4 INDUSTRIAL APPLICATIONS 114
8.4.1 WIDE END-USER BASE WILL DRIVE MARKET GROWTH 114

9 FLOW CYTOMETRY MARKET, BY END USER 115
9.1 INTRODUCTION 116
9.2 ACADEMIC & RESEARCH INSTITUTES 117
9.2.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH 117
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 118
9.3.1 RISING AWARENESS AND DISEASE PREVALENCE HAVE SUSTAINED
THE DEMAND FOR FLOW CYTOMETRY IN HOSPITALS 118

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 119
9.4.1 INCREASE IN DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH 119

10 FLOW CYTOMETRY MARKET, BY REGION 121
10.1 INTRODUCTION 122
10.2 NORTH AMERICA 122
10.2.1 US 126
10.2.1.1 Technological innovation and strategic collaborations are the key drivers of market growth in the US 126
10.2.2 CANADA 128
10.2.2.1 Availability of public and private funding for research activities will boost demand for flow cytometry products in Canada 128
10.3 EUROPE 131
10.3.1 GERMANY 135
10.3.1.1 Strong R&D infrastructure and training and awareness programs have ensured market growth in Germany 135
10.3.2 UK 138
10.3.2.1 UK to witness growing acceptance of flow cytometry products for clinical diagnostics 138
10.3.3 FRANCE 140
10.3.3.1 Training and awareness programs by social organizations and key players are expected to fuel the adoption of flow cytometry 140
10.3.4 ITALY 143
10.3.4.1 Growing use of clinical flow cytometry will favor market growth 143
10.3.5 SPAIN 145
10.3.5.1 High instrument costs and funding limitations have slowed market growth in Spain 145
10.3.6 REST OF EUROPE 147
10.4 ASIA PACIFIC 150
10.4.1 JAPAN 154
10.4.1.1 Strong infrastructure and favorable market outlook have sustained Japan’s dominance in the APAC market 154
10.4.2 CHINA 157
10.4.2.1 China accounts for the second-largest share of the APAC market 157
10.4.3 INDIA 159
10.4.3.1 High incidence of HIV/AIDS and cancer drives demand for flow cytometry instruments in India 159
10.4.4 AUSTRALIA 161
10.4.4.1 Rise in cancer prevalence and awareness on flow cytometry have favored the growth of the Australian market 161
10.4.5 SOUTH KOREA 163
10.4.5.1 Rising awareness and the growing presence of players are driving market growth 163
10.4.6 REST OF ASIA PACIFIC 166

10.5 LATIN AMERICA 169
10.5.1 BRAZIL 172
10.5.1.1 Brazil dominates the LATAM market for flow cytometry 172
10.5.2 MEXICO 174
10.5.2.1 Free trade agreements will support imports and accessibility to flow cytometry instruments in Mexico 174
10.5.3 REST OF LATIN AMERICA 176
10.6 MIDDLE EAST AND AFRICA 178
10.6.1 LOW DISPOSABLE INCOME AND NEED FOR INFRASTRUCTURAL DEVELOPMENT HINDER MARKET GROWTH 178

11 COMPETITIVE LANDSCAPE 182
11.1 INTRODUCTION 182
11.2 COMPETITIVE LEADERSHIP MAPPING 182
11.3 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2018) 183
11.3.1 VISIONARY LEADERS 183
11.3.2 INNOVATORS 183
11.3.3 DYNAMIC DIFFERENTIATORS 183
11.3.4 EMERGING COMPANIES 183
11.4 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2018) 185
11.4.1 PROGRESSIVE COMPANIES 185
11.4.2 STARTING BLOCKS 185
11.4.3 RESPONSIVE COMPANIES 185
11.4.4 DYNAMIC COMPANIES 185
11.5 COMPETITIVE SCENARIO (2016–2019) 187
11.5.1 KEY PRODUCT LAUNCHES AND APPROVALS (2016–2019) 188
11.5.2 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2016–2019) 188
11.5.3 KEY ACQUISITIONS (2016–2019) 189
11.5.4 KEY EXPANSIONS (2016–2019) 190
11.6 GLOBAL MARKET SHARE ANALYSIS, TOP THREE MARKET PLAYERS (2018) 191

12 COMPANY PROFILES 192
(Business overview, Products offered, Recent developments, MNM view)*
12.1 BECTON, DICKINSON AND COMPANY 192
12.2 BECKMAN COULTER (A SUBSIDIARY OF DANAHER) 198
12.3 THERMO FISHER SCIENTIFIC 201
12.4 MERCK KGAA 205
12.5 LUMINEX CORPORATION 210
12.6 AGILENT TECHNOLOGIES 213
12.7 SONY BIOTECHNOLOGY (A SUBSIDIARY OF SONY CORPORATION OF AMERICA) 216
12.8 BIO-RAD LABORATORIES 219
12.9 MILTENYI BIOTEC 222
12.10 ENZO LIFE SCIENCES, INC. (A SUBSIDIARY OF ENZO BIOCHEM) 224
12.11 SYSMEX PARTEC (A SUBSIDIARY OF SYSMEX CORPORATION) 227
12.12 BIOMÉRIEUX SA 230
12.13 CYTONOME/ST, LLC 232
12.14 STRATEDIGM, INC. 233
12.15 APOGEE FLOW SYSTEMS 234
12.16 CYTEK BIOSCIENCES, INC. 235
12.17 OTHER COMPANIES 237
12.17.1 SARTORIUS AG 237
12.17.2 UNION BIOMETRICA, INC. 238
12.17.3 NANOCELLECT BIOMEDICAL, INC. 238
12.17.4 ON-CHIP BIOTECHNOLOGIES CO., LTD. 239
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 240
13.1 DISCUSSION GUIDE 240
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245
13.3 AVAILABLE CUSTOMIZATIONS 247
13.4 RELATED REPORTS 247
13.5 AUTHOR DETAILS 248

 

LIST OF TABLES

TABLE 1 IMPORTANT TECHNOLOGICAL ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2016–2019 47
TABLE 2 IMPORTANT SOFTWARE-RELATED ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2016–2019 49
TABLE 3 INCIDENCE OF HIV/AIDS, BY REGION, 2018 52
TABLE 4 CANCER INCIDENCE AND PREVALENCE DATA, BY COUNTRY, 2018 53
TABLE 5 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA 56
TABLE 6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 62
TABLE 7 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2017–2025 (USD MILLION) 64
TABLE 8 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2017–2025 (USD MILLION) 65
TABLE 9 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2017–2025 (USD MILLION) 67
TABLE 10 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY REGION,
2017–2025 (USD MILLION) 68
TABLE 11 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 69
TABLE 12 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 69
TABLE 13 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 70
TABLE 14 FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY END USER, 2017–2025 (USD MILLION) 70
TABLE 15 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2017–2025 (USD MILLION) 71
TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2017–2025 (UNITS) 72
TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 72
TABLE 18 FLOW CYTOMETRY INSTRUMENTS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 73
TABLE 19 FLOW CYTOMETRY INSTRUMENTS MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 73
TABLE 20 FLOW CYTOMETRY INSTRUMENTS MARKET, BY END USER,
2017–2025 (USD MILLION) 74
TABLE 21 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION,
2017–2025 (USD MILLION) 74
TABLE 22 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2017–2025 (UNITS) 74
TABLE 23 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE,
2017–2025 (USD MILLION) 75
TABLE 24 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 75
TABLE 25 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 76
TABLE 26 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 76
TABLE 27 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY END USER,
2017–2025 (USD MILLION) 77
TABLE 28 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION,
2017–2025 (USD MILLION) 77
TABLE 29 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY COUNTRY,
2017–2025 (UNITS) 78
TABLE 30 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2017–2025 (USD MILLION) 79
TABLE 31 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2017–2025 (USD MILLION) 79
TABLE 32 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2017–2025 (USD MILLION) 80
TABLE 33 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE,
2017–2025 (USD MILLION) 81
TABLE 34 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 81
TABLE 35 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 82
TABLE 36 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 82
TABLE 37 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY END USER,
2017–2025 (USD MILLION) 83
TABLE 38 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION,
2017–2025 (USD MILLION) 83
TABLE 39 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION,
2017–2025 (UNITS) 84
TABLE 40 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2017–2025 (USD MILLION) 85
TABLE 41 MID-RANGE CELL SORTERS MARKET, BY REGION, 2017–2025 (USD MILLION) 85
TABLE 42 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2017–2025 (USD MILLION) 86
TABLE 43 FLOW CYTOMETRY SERVICES MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 87
TABLE 44 FLOW CYTOMETRY SERVICES MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 87
TABLE 45 FLOW CYTOMETRY SERVICES MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 88
TABLE 46 FLOW CYTOMETRY SERVICES MARKET, BY END USER, 2017–2025 (USD MILLION) 88
TABLE 47 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2017–2025 (USD MILLION) 89
TABLE 48 FLOW CYTOMETRY SOFTWARE MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 90
TABLE 49 FLOW CYTOMETRY SOFTWARE MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 90
TABLE 50 FLOW CYTOMETRY SOFTWARE MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 91
TABLE 51 FLOW CYTOMETRY SOFTWARE MARKET, BY END USER,
2017–2025 (USD MILLION) 91
TABLE 52 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2017–2025 (USD MILLION) 92
TABLE 53 FLOW CYTOMETRY ACCESSORIES MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 92
TABLE 54 FLOW CYTOMETRY ACCESSORIES MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 93
TABLE 55 FLOW CYTOMETRY ACCESSORIES MARKET FOR CLINICAL APPLICATIONS,
BY TYPE, 2017–2025 (USD MILLION) 93
TABLE 56 FLOW CYTOMETRY ACCESSORIES MARKET, BY END USER,
2017–2025 (USD MILLION) 94
TABLE 57 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION,
2017–2025 (USD MILLION) 94
TABLE 58 FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 96
TABLE 59 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2017–2025 (USD MILLION) 97
TABLE 60 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 98
TABLE 61 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2017–2025 (USD MILLION) 98
TABLE 62 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 99
TABLE 63 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY APPLICATIONS,
BY REGION, 2017–2025 (USD MILLION) 100
TABLE 64 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH APPLICATIONS,
BY REGION, 2017–2025 (USD MILLION) 101
TABLE 65 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING APPLICATIONS,
BY REGION, 2017–2025 (USD MILLION) 102
TABLE 66 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 103
TABLE 67 FLOW CYTOMETRY MARKET FOR CELL SORTING APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 104
TABLE 68 FLOW CYTOMETRY MARKET FOR APOPTOSIS APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 104
TABLE 69 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS APPLICATIONS,
BY REGION, 2017–2025 (USD MILLION) 105
TABLE 70 FLOW CYTOMETRY MARKET FOR CELL VIABILITY APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 106
TABLE 71 FLOW CYTOMETRY MARKET FOR CELL COUNTING APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 107
TABLE 72 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 107
TABLE 73 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE,
2017–2025 (USD MILLION) 108
TABLE 74 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 109
TABLE 75 FLOW CYTOMETRY MARKET FOR CANCER APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 110
TABLE 76 FLOW CYTOMETRY MARKET FOR HEMATOLOGY APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 111
TABLE 77 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE APPLICATIONS,
BY REGION, 2017–2025 (USD MILLION) 112
TABLE 78 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION APPLICATIONS,
BY REGION, 2017–2025 (USD MILLION) 113
TABLE 79 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2017–2025 (USD MILLION) 113
TABLE 80 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION,
2017–2025 (USD MILLION) 114
TABLE 81 FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 116
TABLE 82 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2025 (USD MILLION) 118
TABLE 83 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2017–2025 (USD MILLION) 119
TABLE 84 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2025 (USD MILLION) 120
TABLE 85 FLOW CYTOMETRY MARKET, BY REGION, 2017–2025 (USD MILLION) 122
TABLE 86 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 124
TABLE 87 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 124
TABLE 88 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 124
TABLE 89 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (UNITS) 125
TABLE 90 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 125
TABLE 91 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 125
TABLE 92 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 126
TABLE 93 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 127
TABLE 94 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 127
TABLE 95 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 127
TABLE 96 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 128
TABLE 97 US: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 128
TABLE 98 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 129
TABLE 99 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 129
TABLE 100 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 130
TABLE 101 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 130
TABLE 102 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 130
TABLE 103 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 133
TABLE 104 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 133
TABLE 105 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 134
TABLE 106 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (UNITS) 134
TABLE 107 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 134
TABLE 108 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 135
TABLE 109 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 135
TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 136
TABLE 111 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 136
TABLE 112 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 137
TABLE 113 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 137
TABLE 114 GERMANY: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 137
TABLE 115 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 139
TABLE 116 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 139
TABLE 117 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 139
TABLE 118 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 140
TABLE 119 UK: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 140
TABLE 120 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 141
TABLE 121 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 141
TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 142
TABLE 123 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 142
TABLE 124 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 142
TABLE 125 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 143
TABLE 126 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 144
TABLE 127 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 144
TABLE 128 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 144
TABLE 129 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 145
TABLE 130 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 145
TABLE 131 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 146
TABLE 132 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 146
TABLE 133 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 146
TABLE 134 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 147
TABLE 135 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 148
TABLE 136 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 148
TABLE 137 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 148
TABLE 138 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 149
TABLE 139 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 149
TABLE 140 APAC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2017–2025 (USD MILLION) 152
TABLE 141 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 152
TABLE 142 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 153
TABLE 143 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (UNITS) 153
TABLE 144 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 153
TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 154
TABLE 146 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 154
TABLE 147 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 155
TABLE 148 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 155
TABLE 149 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 156
TABLE 150 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 156
TABLE 151 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 156
TABLE 152 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 157
TABLE 153 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 158
TABLE 154 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 158
TABLE 155 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 158
TABLE 156 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 159
TABLE 157 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 160
TABLE 158 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 160
TABLE 159 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 160
TABLE 160 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 161
TABLE 161 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 161
TABLE 162 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 162
TABLE 163 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 162
TABLE 164 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 162
TABLE 165 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 163
TABLE 166 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 163
TABLE 167 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 164
TABLE 168 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 164
TABLE 169 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 165
TABLE 170 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 165
TABLE 171 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 165
TABLE 172 ROAPAC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 166
TABLE 173 ROAPAC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 167
TABLE 174 ROAPAC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 167
TABLE 175 ROAPAC: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 167
TABLE 176 ROAPAC: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 168
TABLE 177 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,
2017–2025 (USD MILLION) 170
TABLE 178 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 170
TABLE 179 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 170
TABLE 180 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (UNITS) 171
TABLE 181 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 171
TABLE 182 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 171
TABLE 183 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 172
TABLE 184 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 173
TABLE 185 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 173
TABLE 186 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 173
TABLE 187 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 174
TABLE 188 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 174
TABLE 189 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 175
TABLE 190 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 175
TABLE 191 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 175
TABLE 192 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 176
TABLE 193 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 176
TABLE 194 ROLA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2017–2025 (USD MILLION) 177
TABLE 195 ROLA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,
2017–2025 (USD MILLION) 177
TABLE 196 ROLA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 177
TABLE 197 ROLA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2017–2025 (USD MILLION) 178
TABLE 198 ROLA: FLOW CYTOMETRY MARKET, BY END USER, 2017–2025 (USD MILLION) 178
TABLE 199 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2017–2025 (USD MILLION) 180
TABLE 200 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET,
BY TYPE, 2017–2025 (USD MILLION) 180
TABLE 201 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET,
BY TYPE, 2017–2025 (UNITS) 180
TABLE 202 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,
2017–2025 (USD MILLION) 181
TABLE 203 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION,
2017–2025 (USD MILLION) 181
TABLE 204 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET, BY END USER,
2017–2025 (USD MILLION) 181

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 28
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 31
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 32
FIGURE 4 MARKET SIZE ESTIMATION: FLOW CYTOMETRY MARKET 33
FIGURE 5 FLOW CYTOMETRY MARKET: DATA TRIANGULATION 35
FIGURE 6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019 VS. 2025 (USD MILLION) 37
FIGURE 7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,
2019 VS. 2025 (USD MILLION) 38
FIGURE 8 FLOW CYTOMETRY MARKET, BY APPLICATION, 2019 VS. 2025 (USD MILLION) 38
FIGURE 9 FLOW CYTOMETRY MARKET, BY END USER, 2019 VS. 2025 (USD MILLION) 39
FIGURE 10 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 40
FIGURE 11 GROWING ADOPTION OF FLOW CYTOMETRY IN RESEARCH AND TECHNOLOGICAL ADVANCEMENTS ARE THE MAJOR FACTORS DRIVING MARKET GROWTH 42
FIGURE 12 REAGENTS AND CONSUMABLES TO ACCOUNT FOR LARGEST SHARE TILL 2025 43
FIGURE 13 RESEARCH APPLICATIONS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET TILL 2025 44
FIGURE 14 HOSPITALS AND CLINICAL TESTING LABORATORIES WILL ACCOUNT FOR
THE LARGEST MARKET SHARE IN 2025 44
FIGURE 15 ASIA PACIFIC TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD 45
FIGURE 16 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 46
FIGURE 17 CELL-BASED FLOW CYTOMETRY TO DOMINATE THE FLOW CYTOMETRY MARKET DURING THE FORECAST PERIOD 62
FIGURE 18 REAGENTS & CONSUMABLES SEGMENT DOMINATE THE FLOW
CYTOMETRY MARKET 67
FIGURE 19 CLINICAL APPLICATIONS PROJECTED TO SHOW THE HIGHEST GROWTH DURING THE FORECAST PERIOD 96
FIGURE 20 HOSPITALS & CLINICAL TESTING LABORATORIES TO WITNESS HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 116
FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 123
FIGURE 22 EUROPE: FLOW CYTOMETRY MARKET SNAPSHOT 132
FIGURE 23 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT 151
FIGURE 24 LATIN AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 169
FIGURE 25 MIDDLE EAST AND AFRICA: FLOW CYTOMETRY MARKET SNAPSHOT 179
FIGURE 26 FLOW CYTOMETRY MARKET, COMPETITIVE LEADERSHIP MAPPING, 2018 184
FIGURE 27 FLOW CYTOMETRY MARKET, COMPETITIVE LEADERSHIP MAPPING,
2018 (SME/START-UPS) 186
FIGURE 28 KEY DEVELOPMENTS IN THE FLOW CYTOMETRY MARKET, 2016–2019 187
FIGURE 29 FLOW CYTOMETRY MARKET SHARE ANALYSIS (2018) 191
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 192
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 198
FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018) 201
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2018) 205
FIGURE 34 LUMINEX CORPORATION: COMPANY SNAPSHOT (2018) 210
FIGURE 35 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 213
FIGURE 36 SONY CORPORATION: COMPANY SNAPSHOT (2018) 216
FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2018) 219
FIGURE 38 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2018) 224
FIGURE 39 SYSMEX CORPORATION: COMPANY SNAPSHOT (2018) 227
FIGURE 40 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2018) 230
"

 

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る